Company Filing History:
2 out of 2 
2 out of 5 
2 out of 2 Years Active: 2008-2022
Title: Innovations and Achievements of Scott Lawrence Childs
Introduction
Scott Lawrence Childs, an accomplished inventor based in Atlanta, GA, has made significant contributions to the field of pharmaceuticals. With a portfolio of nine patents, his work focuses on innovative treatments for diseases associated with the activity of sphingosine-1-phosphate (S1P) and related compounds.
Latest Patents
Among his latest inventions is a patent for solid forms of an S1P-receptor modulator. This application relates to the development of solid forms that are useful in treating CNS disorders and various other diseases linked to S1P activity. Furthermore, he has patented crystalline forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione. This invention includes several novel cocrystals, such as a urea cocrystal, a gallic acid cocrystal, a propyl gallate cocrystal, and an L-tartaric acid cocrystal, all aimed at enhancing the pharmaceutical applications of this compound.
Career Highlights
Throughout his career, Scott has collaborated with notable organizations such as New Form Pharmaceuticals Inc. and Aptuit (West Lafayette), LLC. His innovative research and patent filings have positioned him as a key player in the pharmaceutical industry, contributing to advancements in drug formulations and therapeutic uses.
Collaborations
Scott Lawrence Childs has worked alongside prominent colleagues, including Shreenivas R Lingireddy and Nathan Barishansky. These collaborations have enabled him to develop and refine his patented inventions, fostering an environment of shared knowledge and innovation.
Conclusion
In conclusion, Scott Lawrence Childs stands out as a significant inventor in the pharmaceutical sector, with a robust portfolio of patents that showcase his innovative spirit. His commitment to developing novel treatments illustrates his dedication to improving patient outcomes and advancing medical science.